Synairgen plc (LON:SNG – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Friday . The company traded as low as GBX 2 ($0.03) and last traded at GBX 2 ($0.03), with a volume of 4307056 shares traded. The stock had previously closed at GBX 3.75 ($0.05).
Synairgen Price Performance
The company’s 50-day moving average price is GBX 4.46 and its 200-day moving average price is GBX 4.41. The firm has a market cap of £4.03 million, a price-to-earnings ratio of -66.67 and a beta of -2.23. The company has a quick ratio of 6.35, a current ratio of 6.77 and a debt-to-equity ratio of 0.09.
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Read More
- Five stocks we like better than Synairgen
- What Investors Need to Know About Upcoming IPOs
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- What Are Growth Stocks and Investing in Them
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
